Greg D. Aunan
Known title: Chief Accounting OfficerCIK: 0001646370
Associated companies
Transaction History
| NEO | ▼ Sell | Open Market | 20,000 | $321K | 8/4/2026 | View on chart |
| NEO | ▲ Buy | Option Exercise | 5,372 | $0 | 5/2/2026 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 1,309 | $0 | 5/2/2026 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 937 | $0 | 5/1/2026 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 1,875 | $0 | 2/21/2026 | View on chart |
| NEO | ▲ Buy | Option Exercise | 6,323 | $0 | 2/21/2026 | View on chart |
| NEO | ▲ Buy | Option Exercise | 5,372 | $0 | 5/2/2025 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 1,309 | $0 | 5/2/2025 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 937 | $0 | 5/1/2025 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 937 | $0 | 5/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
NeoGenomics Shares Drop 12% on CEO Transition News
NeoGenomics stock fell 12% following the announcement of a CEO succession plan, despite reporting a revenue beat and a strong Q3 outlook. The market reaction highlights how leadership changes can outweigh immediate financial results. Analysts remain mixed, with StoneX raising its price target to $20 while the average target sits at $21.55.
NeoGenomics Shares Drop 12% on CEO Transition News. NeoGenomics stock fell 12% following the announcement of a CEO succession plan, despite reporting a revenue beat and a strong Q3 outlook. The market reaction highlights how leadership changes can outweigh immediate financial results. Analysts remain mixed, with StoneX raising its price target to $20 while the average target sits at $21.55.